Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.

[1]  S. Boorjian,et al.  Survival after complete surgical resection of multiple metastases from renal cell carcinoma , 2011, Cancer.

[2]  P. Russo,et al.  Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma. , 2011, The Journal of urology.

[3]  S. Horie,et al.  Late recurrence of renal cell carcinoma: retrospective and collaborative study of the Japanese Society of Renal Cancer. , 2011, Urology.

[4]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[5]  J. Cheville,et al.  Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol , 2009, BJU international.

[6]  Xin Huang,et al.  Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Patard,et al.  Cancer‐specific and non‐cancer‐related mortality rates in European patients with T1a and T1b renal cell carcinoma , 2009, BJU international.

[8]  S. Boorjian,et al.  The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. , 2008, European urology.

[9]  S. Boorjian,et al.  Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy. , 2008, The Journal of urology.

[10]  M. Cooperberg,et al.  Renal cell cancer stage migration , 2008, Cancer.

[11]  B. Hollenbeck,et al.  Five‐year survival after surgical treatment for kidney cancer , 2007, Cancer.

[12]  J. Cheville,et al.  Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score. , 2007, The Journal of urology.

[13]  I. Gill,et al.  The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. , 2006, The Journal of urology.

[14]  Stephanie Daignault,et al.  Rising Incidence of Small Renal Masses: A Need to Reassess Treatment Effect , 2006 .

[15]  P. Russo,et al.  Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  J. Lam,et al.  Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. , 2005, The Journal of urology.

[17]  Mythreyi Bhargavan,et al.  Utilization of radiology services in the United States: levels and trends in modalities, regions, and populations. , 2005, Radiology.

[18]  J. Cheville,et al.  A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. , 2003, The Journal of urology.

[19]  J. Cheville,et al.  Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma , 2003, Cancer.

[20]  R. Figlin,et al.  Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  J. Cheville,et al.  An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. , 2002, The Journal of urology.

[22]  R. Figlin,et al.  Validation of the ucla integrated staging system for patients with renal cell carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  M. Kattan,et al.  A postoperative prognostic nomogram for renal cell carcinoma. , 2001, The Journal of urology.

[24]  R. Figlin,et al.  Improved prognostication of renal cell carcinoma using an integrated staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  M Mazumdar,et al.  Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J L Warren,et al.  Rising incidence of renal cell cancer in the United States. , 1999, JAMA.

[27]  M Jayson,et al.  Increased incidence of serendipitously discovered renal cell carcinoma. , 1998, Urology.

[28]  York Springer,et al.  Ajcc Cancer Staging Manual. 7th Ed. New , 2010 .

[29]  M. Kattan,et al.  A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. , 2005, The Journal of urology.

[30]  I. Frank,et al.  Prediction of site-specific metastases in surgically treated nonmetastatic renal cell cancer , 2004 .

[31]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.